STOCK TITAN

TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX) announced that its management team will engage in a virtual fireside chat during the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 4:30 p.m. ET. This discussion will be accessible via a live and archived webcast in the Investors section of the TransMedics website. Based in Andover, Massachusetts, TransMedics is pioneering portable organ perfusion technology to enhance organ transplantation outcomes, addressing critical needs in heart, lung, and liver failure treatment.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., July 28, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a virtual fireside chat at the upcoming Canaccord Genuity 41st Annual Growth Conference. The fireside chat will take place on Wednesday, August 11, 2021 at 4:30 p.m. Eastern Time.

Event: Canaccord Genuity 41st Annual Growth Conference
Date: Wednesday, August 11, 2021
Time: 4:30 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-canaccord-genuity-41st-annual-growth-conference-301343547.html

SOURCE TransMedics Group, Inc.

FAQ

When is the TransMedics fireside chat at the Canaccord Genuity conference?

The TransMedics fireside chat is scheduled for August 11, 2021, at 4:30 p.m. ET.

Where can I watch the TransMedics fireside chat?

You can watch the TransMedics fireside chat live and on-demand via the Investors section of their website.

What is the focus of TransMedics Group's technology?

TransMedics focuses on portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

What is the significance of the Canaccord Genuity conference for TransMedics?

The Canaccord Genuity conference provides a platform for TransMedics to discuss its innovative technologies and growth strategies.

What does TransMedics aim to achieve with its organ transplant technology?

TransMedics aims to improve organ quality, assess viability, and enhance the utilization of donor organs for transplantation.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.03B
32.48M
3.18%
112.86%
26.74%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER